Streetbeat News

Stock Prices

MYTE

MYT Netherlands Parent (MYTE) reported a significant decrease in Q2 adjusted EPS from $0.13 last year to $0.04 this year, missing the consensus estimate. Sales increased 9.31% YoY to $212.08M but fell short of the $216.27M estimate.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 11:11 am

WST

West Pharmaceutical Services projects its 2024 sales to be between $3B-$3.025B with an adjusted EPS of $7.50-$7.75, falling short of the consensus estimates of $3.21B in sales and an EPS of $8.76.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 11:09 am

AUPH

Aurinia Pharmaceuticals has announced the initiation of a share repurchase program, allowing the company to buy back up to $150 million of its own shares. This move is a significant financial strategy that could impact the company's stock value and investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 11:09 am

CI

Cigna announced a $3.2B share repurchase through agreements with Deutsche Bank and Bank of America, part of its ongoing buyback program, with $10.6B authority remaining as of February 13, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 11:08 am

CRBG

Corebridge Financial (NYSE:CRBG) reported Q4 2023 adjusted EPS of $1.04, surpassing the $0.97 estimate, with sales of $5.92B exceeding the $5.49B estimate. This represents a 10.90% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 11:08 am

CGNX

Cognex (NASDAQ:CGNX) reported Q4 adjusted EPS of $0.11, surpassing the $0.10 estimate, and sales of $196.67M, exceeding the $188.59M estimate. However, this represents a 59.26% decrease in earnings and a 17.86% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 11:07 am

YETI

YETI Holdings, Inc. forecasts a 7%-9% increase in adjusted sales for 2024, with an adjusted EPS range of $2.45-$2.50, which is below the estimated $2.68.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 11:07 am

CVE

Cenovus Energy (NYSE:CVE) reported Q4 2023 earnings of C$0.39 per share, missing the consensus estimate of $0.48 by 18.75%. However, their quarterly sales of C$13.10 billion exceeded the estimate of $12.85 billion by 1.98%, marking a 24.79% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 11:02 am

WD

Walker & Dunlop reported Q4 adjusted EPS of $1.42, surpassing the $0.80 estimate, a 77.5% beat, and a slight 0.71% increase from last year's $1.41. However, their sales of $274.34M fell short of the $276.76M estimate by 0.88%, marking a 3.01% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 11:02 am

GEL

Genesis Energy (NYSE:GEL) reported a Q4 EPS of $(0.08), missing the $0.23 estimate, representing a 153.33% decrease from last year. However, their sales of $774.10M exceeded the $401.53M estimate, marking an 8.41% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 11:02 am